Events

Recall of SERAFOL cards (pre-transfusion control cards)

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by BIOTEST.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2001-05-28
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-de-lots-du-reactif-cartes-serafol-cartes-de-controle-pretransfusionnel
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    Lots 121100 and 030301 of the reagent called SERAFOL cards (pre-transfusion control cards) - ref. BG1704, BIOTEST are withdrawn from the market due to a possible defect in the packaging that may cause a lack of reactivity of the dried antibodies constituting the cards.

Device

SERAFOL cards (pre-transfusion control cards)
  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer
    BIOTEST

Manufacturer

BIOTEST
  • Source
    LAANSM